Mary Feng, MD
Professor of Radiation Oncology; Medical Director of the Clinical Research Network Office (CRNO), UCSF
Dr. Mary Feng specializes in treatment of gastrointestinal and hepatobiliary cancers. Her research focuses on technical and biological methods to individualize and adapt radiotherapy for each patient with pancreas and liver cancer to maximize the effectiveness of treatment. Her primary goals are 1) Improving outcomes for patients with pancreas and liver cancer through novel combination treatments; 2) Adapting radiotherapy based on early blood and imaging biomarkers of tumor response and treatment effects on nearby organs; and 3) Evaluating the use of advanced technologies in radiotherapy.
Dr. Feng is Vice-Chair for Clinical Research for Radiation Oncology and the Medical Director of the Clinical Research Network Office for the Helen Diller Family Comprehensive Cancer Center. She has been the Clinical Site Director for Mission Bay and Director of Quality Assurance and Safety for the Department of Radiation Oncology at UCSF. She also has served on numerous national and international cancer organization panels and groups, including the National Comprehensive Cancer Network Pancreatic Adenocarcinoma Panel, the American Society of Clinical Oncology Gastrointestinal Cancer Guideline Advisory Group, and the American Society for Radiation Oncology IHE-RO Clinical Advisory Subcommittee as co-chair.
Stanford University, Stanford, CA, BS with Honors, 06/1997, Biological Sciences
Washington University School of Medicine, MD, 05/2002
University of Michigan Medical Center, Intern, 06/2003, Preliminary Medical
University of Michigan Medical Center, Resident, 06/2006, Radiation Oncology
University of Michigan Medical Center, Chief Resident, 06/2007, Radiation Oncology